| Document |
Document Title |
|
WO/2012/056901A1 |
This resist composition comprises at least a base resin, a photo-acid generator and a solvent, wherein the photo-acid generator is a fluorinated sulfonic acid salt represented by general formula (4). (In the formula, X represents a hydro...
|
|
WO/2012/058219A2 |
The subject invention provides deuterated rasagiline, its salts and uses.
|
|
WO/2012/054097A1 |
There is disclosed a process for making a mono-lithium salt of 5-sulfoisophthalic acid (LiSIPA) having less than 500 ppm sulfate. The process uses a reaction mixture of water, a lithium cation producing compound, and 5-sulfoisophthalic a...
|
|
WO/2012/050922A2 |
Gastric retentive dosage forms for sustained reiease of acamprosate are described which may allow once- or twice-daily dosing for both acute and long-term treatment of a disorder including alcohol dependence, tinnitus, sleep apnea, Parki...
|
|
WO/2012/050015A1 |
According to the invention, a sulfonate resin having a repeating unit represented by general formula (3) is provided. In formula (3), X represents a hydrogen atom or a fluorine atom; n represents an integer of 1 to 10; R1 represents a hy...
|
|
WO/2012/045849A1 |
The present invention relates to a new method for the preparation of (3S,3S') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate
A.
|
|
WO/2012/044719A1 |
Embodiments in accordance with the present invention provide for norbornane-type ballast materials, norbornane-type photoactive compounds derived from such ballast materials and alkali-soluble positive-tone polymer compositions that enco...
|
|
WO/2012/042621A1 |
Provided are a compound having a salty taste enhancing action and a salty taste enhancer and the like containing that compound. The salty taste enhancer, which is for food products, contains a compound represented by Formula (I) or an ed...
|
|
WO/2012/038943A1 |
The present invention relates to certain sulfone acetic acid derivatives of formula I as MMP inhibitor and processes for its syntheses. The invention also relates to pharmacological compositions containing the compounds of the present in...
|
|
WO/2012/039024A1 |
Disclosed are a method and a device for recovering a perfluoroalkanesulfonyl fluoride, the method comprising bringing a gas consisting mainly of a perfluoroalkanesulfonyl fluoride represented by the general formula CnF2n+1SO2F (n is an i...
|
|
WO/2012/035122A1 |
The present invention relates to a compound comprising a substituted or unsubstituted anthraquinone, or a salt or isomer thereof, for use in treating a disorder caused by or associated with dysfunctional ion channel activity. The inventi...
|
|
WO/2012/036267A1 |
Provided is a novel developer capable of achieving a heat-sensitive recording material having extremely high color development sensitivity, providing good image density even when printing at a low applied energy (in other words, high bui...
|
|
WO/2012/033798A1 |
A process for the purification of fluoroalkanesulfonate salt comprising (a) contacting a mixture of said salt and an inorganic salt contaminant with a solvent to selectively dissolve said fluoroalkanesulfonate salt in solution, and (b) i...
|
|
WO/2012/030181A2 |
The present invention relates to a compound for the preparation of a natural gas hydrate, and more specifically, to a method for using a multi-chain type surfactant having two or three hydrophobic groups and two sulfate or sulfonate grou...
|
|
WO/2012/029758A1 |
The purpose of the present invention is to provide a photosensitive resin composition having high photosensitivity, excellent transparency in a cured film, and wide developing tolerance, and to provide a method for forming a cured film u...
|
|
WO/2012/029411A1 |
Disclosed is a method for producing a biaryl compound represented by formula (2) shown below, which comprises a step wherein a compound represented by formula (1) shown below is coupled in the presence of an amine compound that has at le...
|
|
WO/2011/010997A9 |
Sulfo-estolides and methods of making them are described. Also described are phase-stable compositions formed from mixtures of different salts of sulfo-estolides, particularly mixtures of sodium and potassium salts of sulfo-estolides, an...
|
|
WO/2012/024282A2 |
This invention relates to compounds of Formula (I), (II), or (III) as shown in the specification, which contain a 1,5-diphenylpenta-1,4-dien-3-one backbone. These compounds can be used to treat cancer, inflammatory disease, or autoimmune...
|
|
WO/2012/023374A1 |
The purpose of the present invention is to provide a radiation-sensitive composition capable of forming a chemically amplified positive resist film which effectively responds to (extreme) far UV light such as a KrF excimer laser, an ArF ...
|
|
WO/2012/020627A1 |
The purpose of the present invention is to provide a radiation sensitive composition, or similar, capable of depositing a chemically amplified positive resist film which is effectively sensitive to KrF excimer lasers, ArF excimer lasers,...
|
|
WO/2012/016780A1 |
Aromatic perfluoroalkane monomer that can be used for the synthesis of a polymer membrane for a fuel cell of PEM type, corresponding to the formula (I): Z1 - Ar3 - C(O) - Ar1- (CF2)n - Ar2 - C(O) - Ar4 - Z2 in which: - n is within a rang...
|
|
WO/2012/014994A1 |
Provided is a compound which can regulate a VCP activity. Specifically provided is a compound represented by formula (I) (wherein R is as defined in the description) or an oxide, ester, prodrug, pharmaceutically acceptable salt or solvat...
|
|
WO/2012/010752A1 |
The invention relates to a process for preparing salts of formulae (RfSO3)n Xn+ (I) or [(RfSO2)(RSO2)N]nXn+ (II) in which: - Rf represents any radical comprising one or more fluorine atoms, - n is an integer varying from 1 to 6, - X is a...
|
|
WO/2011/151669A1 |
The present invention relates to an economic and efficient process for producing enatiomerically enriched 3-(1-aminoethyl)phenyl derivative and employing the same to produce Rivastigmine or its pharmaceutically acceptable salt.
|
|
WO/2011/143819A1 |
Disclosed a process for preparing a phenol ortho-substituted by an electron-donating group and protected in the form of a sulphonic ester which comprises reacting a phenol ortho- substituted by an electron-donating group with a sulphonyl...
|
|
WO/2011/134763A1 |
The invention relates to a new process for the production and/or purification of the salt of the compound (S)-2-[4-(2-fluorobenzyloxy) benzylamino]propanamide, i.e. ralfinamide, or the respective R-enantiomer, with methanesulfonic acid i...
|
|
WO/2011/130831A1 |
There is provided a crystalline form of Lapatinib, termed APO-I, and methods for making APO-I. There is also provided a crystalline solvate form of Lapatinib, termed APO-II, and methods for making APO-II.
|
|
WO/2011/118843A1 |
Glutamate derivatives represented by general formula (I) or salts thereof; pharmaceutical compositions containing these compounds; and CaSR agonists containing the compounds. In general formula (I), R1, R2, R3, R4 and R5 are each indepen...
|
|
WO/2011/113718A1 |
The present invention relates to a cosmetic composition containing a combination i) of at least one screening agent of the dibenzoylmethane derivative type and ii) of at least one particular hydrophilic or water-soluble merocyanin UV-scr...
|
|
WO/2011/111762A1 |
Disclosed are a novel binaphthyl derivative, a novel formylarene derivative and a method capable of producing diaryl derivatives having an asymmetric structure or formylarenes having two specific substituent groups. Using a diformyl-diar...
|
|
WO/2011/108690A1 |
The disclosed composition containing a compound represented by general formula (I) (refer to the Description for the definitions of the symbols used in the formula), or a salt thereof, has excellent CaSR agonist effects and provides phar...
|
|
WO/2011/108563A1 |
A heat-stable solution of an alkyl methanesulfonate in an aromatic organic solvent can be prepared by: reacting an alkyl alcohol with methanesulfonyl chloride in an aromatic organic solvent in the presence of a tertiary amine; and then s...
|
|
WO/2011/109047A2 |
Sulfometh lsuccinates of the formula I, wherein R is an alkyi, alkenyl, alkynyl, alkoxylated alkyi, cycloalkyl, cycloalkenyl, cycloalkynyl, branched alkyi, branched alkenyl, branched alkynyl, branched alkoxylated alkyi, aromatic, substit...
|
|
WO/2011/107465A1 |
The invention relates to a method for producing 4-chlorobenzene sulphonic acid from 2-chlorobenzene sulphonic acid and/or 3-chlorobenzene sulphonic acid, comprising the reaction of 2-chlorobenzene sulphonic acid and/or 3-chlorobenzene su...
|
|
WO/2011/108724A1 |
An object is to provide a CaSR agonist agent that has excellent CaSR agonist effects, and particularly, a pharmaceutical product that can prevent or remedy diabetes or obesity by the effect of CaSR activation. The aforementioned object i...
|
|
WO/2011/104127A1 |
The invention pertains to a compound generating an acid of the formula (I) or (II), for instance corresponding sulfonium and iodonium salts, as well as corresponding sulfonyloximes, Formula (I) and Formula (II), wherein X is CH2 or CO; Y...
|
|
WO/2011/040497A9 |
Disclosed is a method wherein RH 2ORH 1SO2F is added to hydrofluoric acid so as to form a thick solution (hydrogen bonded complex) and the solution is directly supplied to a liquid phase reaction system in which an F2 gas is used, or alt...
|
|
WO/2011/091719A1 |
Crystalline hydrates of alkyl acyl acetaldehyde sulfites, preparation methods and uses thereof. The molecular formula of the hydrates of alkyl acyl acetaldehyde sulfites is CnH2n+1C(O)CH2CH(OH)SO3M·mH2O, wherein n=8-14, m=0.2-1.5, M is ...
|
|
WO/2011/093497A1 |
Provided is a plasma oxidation-reduction method with which it is possible to control the structure of amino acids and proteins with high and stable reproducibility, by using plasma in order to control the amino acids and proteins that ma...
|
|
WO/2011/093371A1 |
A process for producing a perfluorobutanesulfonic acid salt (PFBS salt) is provided with which it is possible to attain an improvement in yield and a reduction in PFOS salt content. Electrolytic fluorination is conducted in an electrolyt...
|
|
WO/2011/093139A1 |
Disclosed is a sulfonic acid derivative that is characterized by being represented by general formula (1). (1) RCOOCH2CH2CFHCF2SO3 -M+ (In formula (1), R represents a substituted or unsubstituted C1-30 linear, branched, or cyclic hydroca...
|
|
WO/2011/088972A1 |
The invention relates to sulfosuccinates of the general formula (1), where M is hydrogen or a cation and the groups R4 and R5 - independently of each other - are hydrogen or a cation or an alkyl group, wherein no more than one of the gro...
|
|
WO/2011/085339A1 |
An overbased alkylated arylalkyl sulfonate is easy to prepare and is useful as a detergent in various lubricant applications.
|
|
WO/2011/077941A1 |
A radiation-sensitive resin composition comprising: a compound (A) represented by general formula (A) (wherein R1 and R2 independently represent a substituted or unsubstituted univalent hydrocarbon group having 1 to 25 carbon atoms; X an...
|
|
WO/2011/066706A1 |
A non-halogen activating agent, which is the sulfonate formed by sulfonic acid reacting with an organic base，is provided as flux. The sulfonic acid can be alkyl sulfonic acid, alkyl disulfonic acid, hydroxyl sulfonic acid, halogenated ...
|
|
WO/2011/068732A2 |
A process for preparing a highly overbased magnesium alkyltoluene sulfonates comprising: (A) reacting at least one oil soluble alkyltoluene sulfonic acid and at least one source of magnesium, in the presence of a mixture comprising: (i) ...
|
|
WO/2011/064216A1 |
The present invention relates to novel pharmaceutically acceptable salts of R(+)-N-propargyl-1-aminoindane (rasagiline), to processes for their preparation and to pharmaceutical compositions containing them.
|
|
WO/2011/062182A1 |
Provided are a photo-acid generator having good development properties and a cation polymerization initiator having good curing properties, and also provided are a resist composition and cation polymerizable composition that use the phot...
|
|
WO/2011/062988A2 |
A process for preparing an alkylaryl sulfonate comprising (a) reacting at least one meta-xylene compound with olefin or a mixture of olefins having from about 10 to about 20 carbon atoms, in the presence of an acid catalyst, wherein the ...
|
|
WO/2011/058789A1 |
Disclosed is a quinonediazide photosensitizer solution comprising a quinonediazide photosensitizer dissolved in an organic solvent so that the precipitation of the quinonediazide photosensitizer from a positive-type resist composition ca...
|
